C12P13/10

METHOD OF PREPARING GRANULAR FEED ADDITIVE

Provided is a method of preparing a granular feed additive. When the method of preparing a granular feed additive according to one exemplary embodiment is used, it is possible to prepare a granular feed additive including a high content of basic amino acids while preventing hygroscopicity and agglomeration caused by the basic amino acids. In addition, since the method of preparing a granular feed additive according to one exemplary embodiment may omit a process of using hydrochloric acid, which is generally used to neutralize basic amino acids, it is possible to simplify the process and to solve process problems caused by the use of hydrochloric acid.

METHOD FOR PREPARING IMMOBILIZED ARGININE DEIMINASE (ADI) AND PRODUCING [14/15N]-L-CITRULLINE

Arginine deiminase (ADI)-containing genetically engineered Corynebacterium glutamicum (C. glutamicum), a fusion protein cipA-arc, use thereof, and a method for preparing [.sup.14/15N]-L-citrulline through enzymatic catalysis are provided. The ADI-containing genetically engineered Corynebacterium glutamicum (C. glutamicum) has a deposit number of CGMCC No. 19404, which expresses a fusion protein cipA-arc. Both the genetically engineered strain and the fusion protein cipA-arc can be used to convert [.sup.14/15N]-L-arginine into [.sup.14/15N]-L-citrulline.

METHOD FOR PREPARING IMMOBILIZED ARGININE DEIMINASE (ADI) AND PRODUCING [14/15N]-L-CITRULLINE

Arginine deiminase (ADI)-containing genetically engineered Corynebacterium glutamicum (C. glutamicum), a fusion protein cipA-arc, use thereof, and a method for preparing [.sup.14/15N]-L-citrulline through enzymatic catalysis are provided. The ADI-containing genetically engineered Corynebacterium glutamicum (C. glutamicum) has a deposit number of CGMCC No. 19404, which expresses a fusion protein cipA-arc. Both the genetically engineered strain and the fusion protein cipA-arc can be used to convert [.sup.14/15N]-L-arginine into [.sup.14/15N]-L-citrulline.

LYSE VARIANT AND METHOD FOR PRODUCING L-ARGININE BY USING SAME

The present disclosure provides a LysE variant.

LYSE VARIANT AND METHOD FOR PRODUCING L-ARGININE BY USING SAME

The present disclosure provides a LysE variant.

Method for producing an L-amino acid using a bacterium of the family Enterobacteriaceae having a disrupted putrescine degradation pathway

The present invention provides a method for producing L-amino acids such as L-amino acids belonging to the glutamate family by fermentation using a bacterium of the family Enterobacteriaceae, particularly a bacterium belonging to the genus Escherichia, which has been modified to disrupt the putrescine degradation pathway by, for example, inactivation of one gene or several genes from the puuADRCBE gene cluster.

Method for producing an L-amino acid using a bacterium of the family Enterobacteriaceae having a disrupted putrescine degradation pathway

The present invention provides a method for producing L-amino acids such as L-amino acids belonging to the glutamate family by fermentation using a bacterium of the family Enterobacteriaceae, particularly a bacterium belonging to the genus Escherichia, which has been modified to disrupt the putrescine degradation pathway by, for example, inactivation of one gene or several genes from the puuADRCBE gene cluster.

A MICROORGANISM OF GENUS CORYNEBACTERIUM HAVING AN ABILITY TO PRODUCE L-ARGININE AND A METHOD FOR PRODUCING L-ARGININE USING THE SAME

The present invention relates to a microorganism of the genus Corynebacterium having an ability to produce L-arginine, and a method of producing L-arginine using the same.

A MICROORGANISM OF GENUS CORYNEBACTERIUM HAVING AN ABILITY TO PRODUCE L-ARGININE AND A METHOD FOR PRODUCING L-ARGININE USING THE SAME

The present invention relates to a microorganism of the genus Corynebacterium having an ability to produce L-arginine, and a method of producing L-arginine using the same.

SYNERGISTIC COMBINATIONS OF ARGININE-PRODUCING BACTERIA AND/OR AMMONIA-CONSUMING BACTERIA AND CHECKPOINT INHIBITORS AND METHODS OF USE THEREOF
20220226397 · 2022-07-21 ·

Disclosed herein are synergistic compositions and methods using arginine-producing bacteria and/or ammonia-consuming bacteria in combination with a checkpoint inhibitor for use in treating cancer.